GSK's Fully Liquid Menveo Meningococcal Vaccine Approved By European Commission

Benzinga · Nov 27 19:17

GSK's fully liquid Menveo meningococcal vaccine approved by European Commission

●

New fully liquid presentation means reconstitution is not needed before use

●

Formulation supports simplification of vaccination process against invasive meningococcal disease (IMD)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

GSK's Fully Liquid Menveo Meningococcal Vaccine Approved By European Commission

Risk Disclaimer